JODIE HALL: Open Payments
NPI 1801467261 · SALEM, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,427 in 62 payments from 33 companies in 2025. Trend: 2023 $0 · 2024 $319 · 2025 $1,427
Food & beverage: $1,332Education: $95
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $182 |
| BeOne Medicines USA, Inc. | 1 | $123 |
| SEAGEN INC. | 1 | $95 |
| PFIZER INC. | 13 | $91 |
| GENZYME CORPORATION | 3 | $81 |
| Eisai Inc. | 3 | $76 |
| Merck Sharp & Dohme LLC | 3 | $68 |
| Novartis Pharmaceuticals Corporation | 2 | $53 |
| E.R. Squibb & Sons, L.L.C. | 2 | $45 |
| TerSera Therapeutics LLC | 2 | $41 |
Products named: RYBREVANT, BRUKINSA, SARCLISA, Lenvima, KEYTRUDA, PADCEV, Enhertu, PYRUKYND.
Industry payments across OR — which companies pay providers there.
